Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Neurobiol Aging. 2021 Feb 11;102:64–72. doi: 10.1016/j.neurobiolaging.2021.02.008

Table 2.

Effects of amyloid status and APOE ε4 status on CSF SNAP-25 and Ng levels

Overall Model SNAP-25 Ng
F-statistic p F-statistic p
17.3 < 0.0001 13.6 < 0.0001
Parameter Estimate Standard error tStat p Estimate Standard Error tStat p
APOE ε4 carrier 1.30 0.20 6.5 < 0.0001 55.70 133 0.42 N.S.
Amyloid positive 0.69 0.24 2.9 0.004 784 158 4.95 < 0.0001
Age (years) 0.012 0.012 0.98 0.33 23.9 7.87 3.04 0.003
Female sex −0.24 0.19 −1.24 0.22 62.2 129 0.48 N.S.
Education (years) −0.06 0.038 −1.58 0.12 −14.2 25.2 −0.56 N.S.
Intercept 4.89 1.14 4.3 < 0.0001 394 762 0.52 N.S.

CSF SNAP-25 and CSF Ng as a function of APOE ε4 carrier status and amyloid statusa, adjusting for age, sex, and years of education. The estimate reflects the pg/mL change in biomarker levels associated with a unit change in the predictor values.

a

Amyloid-negative if CSF ptau181/Aβ42 < 0.0198; Amyloid-positive if CSF ptau181/Aβ42 ≥ 0.0198 (Schindler et al., 2018).